top of page

Publications

Filter by:

Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases

Publications

Nov 1, 2024

Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases

Read More
Targeted gene panel sequencing of liquid and tissue biopsies reveals actionable genomic alterations in Ghanaian metastatic breast cancer cases
LiquidHALLMARK detects more tissue-confirmed guideline-recommended biomarkers than Guardant360 for lung cancer: a prospective multicenter study

Publications

Jul 1, 2024

LiquidHALLMARK detects more tissue-confirmed guideline-recommended biomarkers than Guardant360 for lung cancer: a prospective multicenter study

Read More
LiquidHALLMARK detects more tissue-confirmed guideline-recommended biomarkers than Guardant360 for lung cancer: a prospective multicenter study
Multi-cancer early detection (MCED) in circulating tumor DNA (ctDNA) using an ultrasensitive mutation-based amplicon next-generation sequencing (NGS) assay.

Publications

May 29, 2024

Multi-cancer early detection (MCED) in circulating tumor DNA (ctDNA) using an ultrasensitive mutation-based amplicon next-generation sequencing (NGS) assay.

Read More
Multi-cancer early detection (MCED) in circulating tumor DNA (ctDNA) using an ultrasensitive mutation-based amplicon next-generation sequencing (NGS) assay.
Association between CH mutation in TET2 and solid cancer in elderly Asian women.

Publications

May 29, 2024

Association between CH mutation in TET2 and solid cancer in elderly Asian women.

Read More
Association between CH mutation in TET2 and solid cancer in elderly Asian women.
Utility of an amplicon-based ctDNA platform for advanced cholangiocarcinomas (CCA) in Asia.

Publications

May 29, 2024

Utility of an amplicon-based ctDNA platform for advanced cholangiocarcinomas (CCA) in Asia.

Read More
Utility of an amplicon-based ctDNA platform for advanced cholangiocarcinomas (CCA) in Asia.
The Emerging Role of ctRNA in Liquid Biopsy - Insights From Two Clinical Trials in Oncogene-Driven Non-Small Cell Lung Cancer

Publications

May 13, 2024

The Emerging Role of ctRNA in Liquid Biopsy - Insights From Two Clinical Trials in Oncogene-Driven Non-Small Cell Lung Cancer

Read More
The Emerging Role of ctRNA in Liquid Biopsy - Insights From Two Clinical Trials in Oncogene-Driven Non-Small Cell Lung Cancer
Real-world experience of an Asian pan-cancer combined DNA/RNA next generation sequencing (NGS) tissue biopsy assay

Publications

Mar 22, 2024

Real-world experience of an Asian pan-cancer combined DNA/RNA next generation sequencing (NGS) tissue biopsy assay

Read More
Real-world experience of an Asian pan-cancer combined DNA/RNA next generation sequencing (NGS) tissue biopsy assay
Initial experience in a real-world Asian cohort with a circulating tumor DNA (ctDNA) mutation-based multi-cancer early detection (MCED) assay

Publications

Nov 1, 2023

Initial experience in a real-world Asian cohort with a circulating tumor DNA (ctDNA) mutation-based multi-cancer early detection (MCED) assay

Read More
Initial experience in a real-world Asian cohort with a circulating tumor DNA (ctDNA) mutation-based multi-cancer early detection (MCED) assay
Amplicon-Based Liquid Biopsy Prospectively Detects More Tissue-Confirmed Guideline-Recommended Biomarkers in Lung Cancer

Publications

Sep 10, 2023

Amplicon-Based Liquid Biopsy Prospectively Detects More Tissue-Confirmed Guideline-Recommended Biomarkers in Lung Cancer

Read More
Amplicon-Based Liquid Biopsy Prospectively Detects More Tissue-Confirmed Guideline-Recommended Biomarkers in Lung Cancer

1

/

8

bottom of page